Effects of eight months treatment with graded doses of a growth hormone (GH)-releasing peptide in GH-deficient children

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 7, 1998, Pages 2355-2360

  Mericq, Verónica ^a   Cassorla, Fernando ^a   Salazar, Teresa ^a   Avila, Alejandra ^a   Iñiguez, Germán ^a   Bowers, Cyril Y ^b   Merriam, George R ^c  

^a UNIVERSITY OF CHILE   (Chile)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR 2; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; SERMORELIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DOSE RESPONSE; DRUG TOLERABILITY; FEMALE; GROWTH DISORDER; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; MALE; PREPUBERTY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HORMONES; HUMAN GROWTH HORMONE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; OLIGOPEPTIDES; SECRETORY RATE;

EID: 0031759899     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.7.2355     Document Type: Article

References (28)

1. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF. 1995 Blocked GHPR-6 induced GH secretion and absence of the synergic action of GHRP-6 plus GHRH in patients with hypothalamopituitary disconnection. J Clin Endocrinol Metab. 80:942-947.
2. Pombo M, Barreiro J, Penalva A, Peino R, Dieguez C, Casanueva FF. 1995 Absence of GH secretion after the administration of either GHRH, GHRP-6, or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection. J Clin Endocrinol Metab. 80:3180-84.
3. Borges JLC, Blizzard RM, Gelato MC, et al. 1983 Effects of human pancreatic growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic GH deficiency. Lancet. 2:119-123.
4. Gelato MC, Malozowski S, Nicoletti MD, et al. 1986 Growth hormone responses to GHRH during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency. J Clin Endocrinol Metab. 63:173-179.
5. Malozowski SN, Cassorla F, Merriam GR, Gelato MC. 1991 Repeated stimulation with growth hormone-releasing hormone can induce a GH response in initially unresponsive patients. J Ped Endocrinol. 4:1-5.
6. Gelato MC, Levine-Ross J, Malozowski S, et al. 1985 Effects of pulsatile administration of GH-releasing hormone on short-term linear growth in children with GH deficiency. J Clin Endocrinol Metab. 61:444-450.
7. Thorner MO, Reschke J, Chitwood J, et al. 1985 Acceleration of growth in two children treated with human growth hormone-releasing factor. N Engl J Med. 312:4-9.
8. Thorner MO, Rogol AD, Blizzard RI, et al. 1988 Acceleration of growth rate in growth hormone deficient children treated with human GHRH. Pediatr Res. 24:145-151.
9. Ross JM, Tsagaraskis S, Grossman A, et al. 1987 Treatment of GH deficiency with GHRH. Lancet. 1:5-8.
10. Rochiccioli P, Tauber MT, Coude FX, et al. 1987 Results of one year growth hormone (GH) releasing hormone (1-44) treatment on growth, somatomedin C, and 24-hour GH secretion in 6 children with partial GH deficiency. J Clin Endocrinol Metab. 65:268-274.
11. Cassorla F, Mericq V, Garcia H, et al. 1995 The effects of β1-adrenergic blockade on the growth response to growth hormone-releasing hormone therapy in growth hormone deficient children. J Clin Endocrinol Metab. 80:2997-3001.
12. Thorner MO, Rochiccioli P, Colle M, et al. 1996 Once daily subcutaenous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children. J Clin Endocrinol Metab. 81:1189-1196.
13. Bowers CY, Momany F, Reynolds GA, Chang D, Hong A, Chang K. 1980 Structure-activity relationships of a synthetic pentapeptide that specifically releases GH in vitro. Endocrinology. 106:663-667.
14. Bowers CY, Sartor OA, Reynolds GA, Badger TM. 1991 On the actions of the CHRP. Endocrinology. 128:2027-2035.
15. Bowers CY, Alster DK, Frents JM. 1992 The growth hormone releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration. J Clin Endocrinol Metab. 74:292-296.
16. Malozowski S, Hao EH, Ren SG, et al. 1991 Growth hormone (GH) responses to the hexapeptide CHRP and GHRH in the cynomolgus macaque: evidence for non-GHRH mediated responses. J Clin Endocrinol Metab. 73:314-317.
17. Bowers CY, Reynolds GA, Durham D, et al. 1990 Growth hormone (GH) releasing peptide stimulates GH release in normal man and acts synergistically with GHRH. J Clin Endocrinol Metab. 70:975-982.
18. Bowers CY. 1993 GH-releasing peptides-structure and kinetics. J Pediatr Endocrinol. 6:21-31.
19. Bowers CY, Veeraragavan K, Sethumadhavan K. 1994 Atypical growth hormone-releasing peptides. In: BB Bercu and RF Walker, eds. Growth hormone II: basic and clinical aspects. New York: Springer; pp 203-222.
20. Patchelt AA, Nargund RP, Tata JR, et al. 1995 Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc Nat Acad Sci USA. 92:7001-7005.
21. Mericq V, Cassorla F, Garcia H, Avila A, Bowers CY, Merriam GR. 1995 Growth hormone (GH) responses to GH-releasing peptide and to GH-releasing hormone in GH-deficient children. J Clin Endocrinol Metab. 80:1681-1684.
22. Rosenfield RG, Albertsson-Wikland K, Cassorla F, et al. 1995 Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab. 80:1532-1540.
23. Merriam GR, Wachter KW. 1982 Algorithms for the study of episodic hormone secretion. Am J Physiol. 243:E310-E318.
24. Pezzoli P, Cacciara E, Mandini M, et al. 1992 Growth and thyroid function in children treated with GH. J Pediatr. 121:210-213.
25. Vitiello MV, Schwartz RS, Reed S, Moe KE, Prinz PN, Merriam GR. 1996 Effect of GHRH-treatment on 24-hour GH secretion of healthy older women. American Geriatrics Society Annual Meeting (Abstract).
26. Frasier SD. 1983 Human pituitary growth hormone (hGH) therapy in growth deficiency. Endocr Rev. 4:155-201.
27. Laron Z, Frenkel J, Deghenghi, Annin S, Klinger B, Silbergeld A. 1995 Intranasal administration of the GHRP hexarelin accelerates growth in short children. Clin Endocrinol. 43:631-635.
28. Pihoker C, Badger TM, Reynolds GA, Bowers CY. 1997 Treatment effects of intranasal growth hormone (GH)-releasing peptide-2 (GHRP-2) in children with short stature. J Clin Endocrinol Metab. In press.